Bezitramide
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile
|
|
| Clinical data | |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 15301-48-1 |
| ATC code | N02AC05 (WHO) |
| PubChem | CID: 61791 |
| DrugBank | DB01459  |
| ChemSpider | 55675 |
| UNII | 3KXW0Y310I |
| ChEMBL | CHEMBL2104149 |
| Chemical data | |
| Formula | C31H32N4O2 |
| Molecular mass | 492.611 g/mol |
|
|
|
|
| (verify) | |
Bezitramide is an opioid analgesic. Bezitramide itself is a prodrug which is readily hydrolyzed in the gastrointestinal tract to its main metabolite, despropionyl-bezitramide. Bezitramide was discovered at Janssen Pharmaceutica in 1961.[1][2][3] It is most commonly marketed under the trade name Burgodin.
The drug was pulled from the shelves in the Netherlands in 2004 after fatal overdose cases, including one where a five-year-old child took one tablet from his mother's purse, ate it, and promptly died.[4]
Bezitramide is regulated much the same as morphine in all known jurisdictions and is a Schedule II substance under the United States' Controlled Substances Act of 1970, with an ACSCN of 9800 and zero annual manufacturing quota.[5] However, it has to this point never been marketed in the United States.
References
- ↑ US patent 3196157, Paul A. J. Janssen., "BENZIMIDAZOLINYL PIPERIDINES", published 1963-06-11, issued 1965-07-20
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Title 21 United States Code (USC) Controlled Substances Act
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
